Diagnostic Leasing Inc is categorized under Business Management Consultants in Van Nuys, CA and active since 1987.
Diagnostic Leasing Inc was established in 1987, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Business Management Consultants business, which does work in the B2B market, and is classified as a Business Management Consultants, under code number 541611 by the NAICS.
If you are seeking more information, feel free to contact Orlando Cano at the company’s single location by writing to 14624 Sherman Way # 406, Van Nuys, California CA 91405 or by phoning (818) 989-9991. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Diagnostic Leasing Inc |
| Contact Person: | Orlando Cano |
| Address: | 14624 Sherman Way # 406, Van Nuys, California 91405 |
| Phone Number: | (818) 989-9991 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1987 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Management Consultants |
| SIC Code: | 8742 |
| NAICS Code: | 541611 |
| Share This Business: |
Diagnostic Leasing Inc was started in 1987 to provide professional Business Management Consultants under the SIC code 8742 and NAICS code 541611. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Orlando Cano for inquiries that concern Diagnostic Leasing Inc by calling the company number (818) 989-9991, as your correspondence is most welcome. Additionally, the physical location of the single location of Diagnostic Leasing Inc can be found at the coordinates 34.201048,-118.452187 as well as the street address 14624 Sherman Way # 406 in Van Nuys, California 91405.
For its online presence, you may visit Diagnostic Leasing Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.